Aries Biotech LLP

Aries Biotech LLP - pharma in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
LLPIN AAN-1438 Incorporated 13 August 2018 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · FY 2026
₹7.47 Lakh
▼ 46% YoY
Net profit · FY 2026
₹5.01 Lakh
Net margin 67.1%
EBITDA · FY 2026
₹7.46 Lakh
EBITDA margin 99.9%
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
8 yrs
Est. 2018
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data

About Aries Biotech LLP

Data last updated:

Aries Biotech LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAN-1438.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Kantilal Ishvarlal Patel and Arish Kantilal Patel.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at C – 1/260 Phase II GIDC Estate Vatva, Ahmedabad, Gujarat, India – 382445.

As per the financials filed for FY 2026, the LLP reported a revenue of ₹7.47 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹5.01 Lakh (net margin 67.1%) and EBITDA of ₹7.46 Lakh (EBITDA margin 99.9%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.

Company Details of Aries Biotech LLP
LLPIN AAN-1438
Incorporation Date 13 August 2018
Total Obligation of Contribution ₹1 Lakh
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Kantilal Ishvarlal Patel Designated Partner Arish Kantilal Patel Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C – 1/260 Phase II GIDC Estate Vatva, Ahmedabad, Gujarat, India – 382445
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Aries Biotech LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Aries Biotech LLP report

Financials, compliance, directors, charges, ownership and filings for Aries Biotech LLP in one report.

Financials from FY 2019 Directors & ownership Charges & compliance

Financials of Aries Biotech LLP FY 2025 filings available

Aries Biotech LLP reported revenue of ₹7.47 Lakh (down 46% YoY) for FY 2026.

Revenue · FY 2026
₹7.47 Lakh ▼ 46%
Net profit · FY 2026
₹5.01 Lakh margin 67.1%
EBITDA · FY 2026
₹7.46 Lakh margin 99.9%

Compounded Annual Growth Rate (CAGR) of Aries Biotech LLP

Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 8%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 8%
5 years · compounded
▼ 5%

Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 46% fall in the latest year. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Aries Biotech LLP

Statement of Account and SolvencyFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax₹5.01 Lakh••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Aries Biotech LLP

Statement of Account and SolvencyFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
Net Profit Margin67.1%••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Aries Biotech are in the company report.

Premium access

Financial statements from FY 2019

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Aries Biotech LLP

Aries Biotech has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Kantilal Ishvarlal Patel
Also directs: Aries Colorchem Private Limited, Aries Organics Private Limited, Vibrant Industrial Park Limited
Designated Partner13 Aug 20188 Years 2 MonthsCurrent
Arish Kantilal Patel
Also directs: Aries Colorchem Private Limited, Aries Organics Private Limited
Designated Partner13 Aug 20188 Years 2 MonthsCurrent
View all designated partners

Charges & Borrowings of Aries Biotech LLP

Aries Biotech LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Aries Biotech LLP

Employment history and EPFO contributions of people linked to Aries Biotech.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Aries Biotech LLP

Aries Biotech LLP has 2 designated partner changes on record since 2018: 2 appointments. The latest: Arish Kantilal Patel was appointed as Designated Partner on 13 Aug 2018.

AGM
Aries Biotech Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Aries Biotech Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Arish Kantilal Patel was appointed as Designated Partner.
Appointed
Kantilal Ishvarlal Patel was appointed as Designated Partner.
Incorporation
13 Aug 2018
Aries Biotech Llp was registered on 13 Aug 2018 with Roc Ahmedabad & aged 8 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Aries Biotech LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aries Biotech LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aries Biotech LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Aries Biotech LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aries Biotech LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aries Biotech LLP

Aries Biotech is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2018 (8+ years old) and is registered under LLPIN AAN-1438.

Aries Biotech reported revenue of ₹7.47 Lakh for FY 2026 (down 46% YoY).

Aries Biotech has 2 current designated partners:

Aries Biotech reported a net profit of ₹5.01 Lakh (net margin 67.1%) and EBITDA of ₹7.46 Lakh (EBITDA margin 99.9%) for FY 2026, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Aries Biotech is -8% over three years and -5% over five years. In the latest year (FY 2026) revenue fell 46%. CAGR is the steady yearly rate that links the first and the last year.

The LLPIN (Limited Liability Partnership Identification Number) of Aries Biotech is AAN-1438. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aries Biotech was incorporated on 13 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Arish Kantilal Patel was appointed as Designated Partner on 13 Aug 2018. Kantilal Ishvarlal Patel was appointed as Designated Partner on 13 Aug 2018.

The registered office of Aries Biotech is at C – 1260 Phase II GIDC Estate Vatva, Ahmedabad, Gujarat, India – 382445.

The total obligation of contribution is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available